Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol

Overview

Journal Front Physiol

Date 2018 Jun 6

PMID 29867567

Citations 56

Authors

Leandro R Marques

Tiego A Diniz

Barbara M Antunes

Fabricio E Rossi

Erico C Caperuto

Fabio S Lira

Daniela C Goncalves

Affiliations

Soon will be listed here.

Abstract

Dyslipidemia (high concentrations of LDL-c and low concentrations of HDL-c) is a major cause of cardiovascular events, which are the leading cause of death in the world. On the other hand, nutrition and regular exercise can be an interesting strategy to modulate lipid profile, acting as prevention or treatment, inhibiting the risk of diseases due to its anti-inflammatory and anti-atherogenic characteristics. Additionally, the possibility of controlling different training variables, such as type, intensity and recovery interval, can be used to maximize the benefits of exercise in promoting cardiovascular health. However, the mechanisms by which exercise and nutrients act in the regulation of cholesterol and its fractions, such as reverse cholesterol transport, receptors and transcription factors involved, such as PPARs and their role related to exercise, deserve further discussion. Therefore, the objective of this review is to debate about non-medical approaches to increase HDL-c, such as nutritional and training strategies, and to discuss the central mechanisms involved in the modulation of lipid profile during exercise, as well as that can be controlled by physical trainers or sports specialists in attempt to maximize the benefits promoted by exercise. The search for papers was performed in the databases: Medline (Pubmed), Science Direct, Scopus, Sport Discus, Web of Science, Scielo and Lilacs until February 2016.

Citing Articles

Effects of Physical Exercise on Cardiometabolic Health in Individuals with Autism Spectrum Disorder: A Systematic Review.

Charlier L, Cordeiro L, Cavalcante Neto J, Signini E, Barbosa-Silva J, Corbellini C Healthcare (Basel). 2025; 13(4).

PMID: 39997314 PMC: 11855590. DOI: 10.3390/healthcare13040439.

Trimester-specific reference intervals for blood lipid levels and their associations with adverse pregnancy outcomes in Southeast China.

Yang L, Liu Z, Chen J, Miao C, Li Q, Chen J Lipids Health Dis. 2025; 24(1):68.

PMID: 39987069 PMC: 11846285. DOI: 10.1186/s12944-025-02494-w.

Effects of Nickel Bioaccumulation on Hematological, Biochemical, Immune Responses, Neuroinflammatory, Oxidative Stress Parameters, and Neurotoxicity in Rats.

El Brouzi M, Adadi N, Lamtai M, Boulahfa H, Zghari O, Fath N Biol Trace Elem Res. 2025; .

PMID: 39891830 DOI: 10.1007/s12011-025-04528-x.

Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease.

Rubino J, Ring N, Patel K, Xia X, MacKenzie T, diFlorio-Alexander R Biomedicines. 2025; 13(1.

PMID: 39857664 PMC: 11760488. DOI: 10.3390/biomedicines13010080.

Bile acids and incretins as modulators of obesity-associated atherosclerosis.

Kirsch A, Gindlhuber J, Zabini D, Osto E Front Cardiovasc Med. 2025; 11():1510148.

PMID: 39834741 PMC: 11743266. DOI: 10.3389/fcvm.2024.1510148.

References

Kim H, Jeon S, Lee M, Cho Y, Kwon E, Lee J . Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters. J Med Food. 2010; 13(4):808-14. DOI: 10.1089/jmf.2009.1320. View

REPA J, Turley S, Lobaccaro J, Medina J, Li L, Lustig K . Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 2000; 289(5484):1524-9. DOI: 10.1126/science.289.5484.1524. View

Baba S, Osakabe N, Kato Y, Natsume M, Yasuda A, Kido T . Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr. 2007; 85(3):709-17. DOI: 10.1093/ajcn/85.3.709. View

Loftus H, Astell K, Mathai M, Su X . Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial. Nutrients. 2015; 7(11):9508-22. PMC: 4663611. DOI: 10.3390/nu7115483. View

Olchawa B, Kingwell B, Hoang A, Schneider L, Miyazaki O, Nestel P . Physical fitness and reverse cholesterol transport. Arterioscler Thromb Vasc Biol. 2004; 24(6):1087-91. DOI: 10.1161/01.ATV.0000128124.72935.0f. View

Gervois P, Fruchart J, Staels B . Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nat Clin Pract Endocrinol Metab. 2007; 3(2):145-56. DOI: 10.1038/ncpendmet0397. View

Weggemans R, Trautwein E . Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr. 2003; 57(8):940-6. DOI: 10.1038/sj.ejcn.1601628. View

Hellsten Y, Apple F, Sjodin B . Effect of sprint cycle training on activities of antioxidant enzymes in human skeletal muscle. J Appl Physiol (1985). 1996; 81(4):1484-7. DOI: 10.1152/jappl.1996.81.4.1484. View

Gupta A, Ross E, Myers J, Kashyap M . Increased reverse cholesterol transport in athletes. Metabolism. 1993; 42(6):684-90. DOI: 10.1016/0026-0495(93)90233-e. View

10.

Thushara R, Gangadaran S, Solati Z, Moghadasian M . Cardiovascular benefits of probiotics: a review of experimental and clinical studies. Food Funct. 2016; 7(2):632-42. DOI: 10.1039/c5fo01190f. View

11.

Diniz T, Rossi F, Fortaleza A, Melo Neves L, Christofaro D, Buonani C . Changes in HDL-c concentrations after 16 weeks of combined training in postmenopausal women: characteristics of positive and negative responders. Appl Physiol Nutr Metab. 2017; 43(1):38-44. DOI: 10.1139/apnm-2017-0294. View

12.

Oscai L, Caruso R, Wergeles A . Lipoprotein lipase hydrolyzes endogenous triacylglycerols in muscle of exercised rats. J Appl Physiol Respir Environ Exerc Physiol. 1982; 52(4):1059-63. DOI: 10.1152/jappl.1982.52.4.1059. View

13.

Chapman M, Le Goff W, Guerin M, Kontush A . Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J. 2009; 31(2):149-64. PMC: 2806550. DOI: 10.1093/eurheartj/ehp399. View

14.

Casella-Filho A, Chagas A, Maranhao R, Trombetta I, Cesena F, Silva V . Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome. Am J Cardiol. 2011; 107(8):1168-72. DOI: 10.1016/j.amjcard.2010.12.014. View

15.

Siri-Tarino P . Effects of diet on high-density lipoprotein cholesterol. Curr Atheroscler Rep. 2011; 13(6):453-60. DOI: 10.1007/s11883-011-0207-y. View

16.

Chen G, Wang H, Zhang X, Yang S . Nutraceuticals and functional foods in the management of hyperlipidemia. Crit Rev Food Sci Nutr. 2014; 54(9):1180-201. DOI: 10.1080/10408398.2011.629354. View

17.

Palozza P, Catalano A, Simone R, Mele M, Cittadini A . Effect of lycopene and tomato products on cholesterol metabolism. Ann Nutr Metab. 2012; 61(2):126-34. DOI: 10.1159/000342077. View

18.

Haidari F, Rashidi M, Mohammad-Shahi M . Effects of orange juice and hesperetin on serum paraoxonase activity and lipid profile in hyperuricemic rats. Bioimpacts. 2013; 2(1):39-45. PMC: 3648914. DOI: 10.5681/bi.2012.005. View

19.

Goncalves Panissa V, Julio U, Diniz T, Antunes B, Lira F, Takito M . Postprandial lipoprotein profile in two modes of high-intensity intermittent exercise. J Exerc Rehabil. 2016; 12(5):476-482. PMC: 5091065. DOI: 10.12965/jer.1632666.333. View

20.

Rader D . Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest. 2006; 116(12):3090-100. PMC: 1679714. DOI: 10.1172/JCI30163. View